Recent Finacing
Recent Raise
HiberCell develops therapeutics that target dormant disseminated tumor cells in solid and liquid cancers, using a stress-modulator platform to prevent relapse and metastasis and reprogram immunosuppressive tumor microenvironments.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
